Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 USD | -19.72% | -26.52% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales 1 | 12.85 | 16.16 | 28.23 |
EBITDA 1 | 0.331 | 0.271 | 1.204 |
EBIT 1 | 0.3306 | 0.2688 | 1.196 |
Operating Margin | 2.57% | 1.66% | 4.24% |
Earnings before Tax (EBT) 1 | 0.3253 | 0.2596 | 1.19 |
Net income 1 | 0.3041 | 0.2446 | 0.9698 |
Net margin | 2.37% | 1.51% | 3.44% |
EPS 2 | 0.0122 | 0.009783 | 0.0351 |
Free Cash Flow | - | -0.3381 | -1.235 |
FCF margin | - | -2.09% | -4.37% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 15/02/23 | 15/02/23 | 24/10/23 |
Balance Sheet Analysis
Fiscal Period: June | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 0.15 | 0.1 | - |
Net Cash position 1 | - | - | 0.31 |
Leverage (Debt/EBITDA) | 0.466 x | 0.3517 x | - |
Free Cash Flow | - | -0.34 | -1.23 |
ROE (net income / shareholders' equity) | - | -14.4% | 1,924% |
ROA (Net income/ Total Assets) | - | 10% | 29.9% |
Assets 1 | - | 2.444 | 3.249 |
Book Value Per Share 2 | -0.0800 | -0.0600 | 0.0500 |
Cash Flow per Share 2 | 0 | 0.0100 | 0.0400 |
Capex 1 | 0 | 0.01 | 0.05 |
Capex / Sales | 0.03% | 0.05% | 0.16% |
Announcement Date | 15/02/23 | 15/02/23 | 24/10/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 15Cr | |
+21.85% | 2.72TCr | |
+5.38% | 1.79TCr | |
-4.43% | 1.2TCr | |
-9.38% | 1.12TCr | |
-0.42% | 1TCr | |
+5.16% | 433.81Cr | |
-2.89% | 330.03Cr | |
-25.16% | 319.03Cr | |
+11.32% | 306.54Cr |
- Stock Market
- Equities
- HAO Stock
- Financials Haoxi Health Technology Limited